ContractAsset Purchase Agreement • October 31st, 2016 • Oculus Innovative Sciences, Inc. • Pharmaceutical preparations
ASSET PURCHASE AGREEMENT ENTERED INTO BY AND BETWEEN, oculus innovative Sciences, inc., represented By mr. JIM SCHUTZ, hereinafter referred TO AS “ois”, oculus technologies of mexico, S.A. de C.V., represented by mr. EVERARDO GARIBAY RAMÍREZ, hereinafter referred to as “otm”, and collectively with OIS referred to as the “sellers”, and INVEKRA, S.A.P.I. DE C.V., represented By mr. RICARDO GUILLERMO AMTMANN AGUILAR, hereinafter referred TO as “buyer” (all PARTIES referred JOINTLY HEREINBELOW as THE "partIEs”), IN ACCORDANCE with the FOLLOWING background, WHEREAS and clauses:
ContractAmendment Agreement to the Acquisition Option • October 31st, 2016 • Oculus Innovative Sciences, Inc. • Pharmaceutical preparations
AMENDMENT AGREEMENT TO THE ACQUISITION OPTION (THE “AMENDMENT AGREEMENT”), ENTRED INTO BY AND BETWEEN MORE PHARMA CORPORATION, S. DE R.L. DE C.V., REPRESENTED BY MR. RICARDO GUILLERMO AMTMANN AGUILAR, HERINAFTER REFERRED TO AS “MORE PHARMA”, AND OCULUS TECHNOLOGIES OF MEXICO, S.A. DE C.V., REPRESENTED BY MR. EVERARDO GARIBAY RAMÍREZ, HEREINAFTER REFERRED TO AS “OTM”, IN ACCORDANCE WITH THE FOLLOWING BACKGROUND, WHEREAS AND CLAUSES.
